tadalafil

Product NDC
70518-3697
11-digit product format
705183697
Labeler code
70518
Product ID
70518-3697_5ee74e46-f886-4dda-e063-6394a90a70fd
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
tadalafil
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
REMEDYREPACK INC.
Application
ANDA209250
Marketing category
ANDA
Marketing start
2023-04-02
Substance
TADALAFIL
Active strength
5 mg/1
Pharmacologic classes
Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded packagepackage70518-369770518-3697-0DDiscontinued by firm2026-11-06
excluded packagepackage70518-369770518-3697-2DDiscontinued by firm2026-11-06

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A209250-001TADALAFILTADALAFIL2.5MGTABLET / ORALAB12019-03-26
A209250-002TADALAFILTADALAFIL5MGTABLET / ORALAB12019-03-26
A209250-003TADALAFILTADALAFIL10MGTABLET / ORALAB12019-03-26
A209250-004TADALAFILTADALAFIL20MGTABLET / ORALAB12019-03-26

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 4 matching rows.

Application-product, TE code table
Application-productTE code
A209250-001AB1
A209250-002AB1
A209250-003AB1
A209250-004AB1

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 5 · 176 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-10-15 13:18:302026-09A209250-001TADALAFIL2.5MGTABLET / ORALAB12019-03-26c2088c7a36db…
2026-10-15 13:18:302026-09A209250-002TADALAFIL5MGTABLET / ORALAB12019-03-26c2088c7a36db…
2026-10-15 13:18:302026-09A209250-003TADALAFIL10MGTABLET / ORALAB12019-03-26c2088c7a36db…
2026-10-15 13:18:302026-09A209250-004TADALAFIL20MGTABLET / ORALAB12019-03-26c2088c7a36db…
2026-09-14 22:38:342026-08A209250-001TADALAFIL2.5MGTABLET / ORALAB12019-03-2684e616aacf4f…
2026-09-14 22:38:342026-08A209250-002TADALAFIL5MGTABLET / ORALAB12019-03-2684e616aacf4f…
2026-09-14 22:38:342026-08A209250-003TADALAFIL10MGTABLET / ORALAB12019-03-2684e616aacf4f…
2026-09-14 22:38:342026-08A209250-004TADALAFIL20MGTABLET / ORALAB12019-03-2684e616aacf4f…
2026-08-18 06:07:402026-07A209250-001TADALAFIL2.5MGTABLET / ORALAB12019-03-26caaa826d4ba7…
2026-08-18 06:07:402026-07A209250-002TADALAFIL5MGTABLET / ORALAB12019-03-26caaa826d4ba7…
2026-08-18 06:07:402026-07A209250-003TADALAFIL10MGTABLET / ORALAB12019-03-26caaa826d4ba7…
2026-08-18 06:07:402026-07A209250-004TADALAFIL20MGTABLET / ORALAB12019-03-26caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A209250-001TADALAFIL2.5MGTABLET / ORALAB12019-03-26011fe1cb6892…
2026-02-19 14:30 UTC2026-02A209250-002TADALAFIL5MGTABLET / ORALAB12019-03-26011fe1cb6892…
2026-02-19 14:30 UTC2026-02A209250-003TADALAFIL10MGTABLET / ORALAB12019-03-26011fe1cb6892…
2026-02-19 14:30 UTC2026-02A209250-004TADALAFIL20MGTABLET / ORALAB12019-03-26011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A209250-001TADALAFIL2.5MGTABLET / ORALAB12019-03-2631067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A209250-002TADALAFIL5MGTABLET / ORALAB12019-03-2631067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A209250-003TADALAFIL10MGTABLET / ORALAB12019-03-2631067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A209250-004TADALAFIL20MGTABLET / ORALAB12019-03-2631067a03dcf5…
2025-08-23 18:47 UTC2025-08A209250-001TADALAFIL2.5MGTABLET / ORALAB12019-03-266a471c1ec25d…
2025-08-23 18:47 UTC2025-08A209250-002TADALAFIL5MGTABLET / ORALAB12019-03-266a471c1ec25d…
2025-08-23 18:47 UTC2025-08A209250-003TADALAFIL10MGTABLET / ORALAB12019-03-266a471c1ec25d…
2025-08-23 18:47 UTC2025-08A209250-004TADALAFIL20MGTABLET / ORALAB12019-03-266a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A209250-001TADALAFIL2.5MGTABLET / ORALAB12019-03-26fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A209250-002TADALAFIL5MGTABLET / ORALAB12019-03-26fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A209250-003TADALAFIL10MGTABLET / ORALAB12019-03-26fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A209250-004TADALAFIL20MGTABLET / ORALAB12019-03-26fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A209250-001TADALAFIL2.5MGTABLET / ORALAB12019-03-26b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A209250-002TADALAFIL5MGTABLET / ORALAB12019-03-26b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A209250-003TADALAFIL10MGTABLET / ORALAB12019-03-26b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A209250-004TADALAFIL20MGTABLET / ORALAB12019-03-26b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A209250-001TADALAFIL2.5MGTABLET / ORALAB12019-03-2603ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A209250-002TADALAFIL5MGTABLET / ORALAB12019-03-2603ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A209250-003TADALAFIL10MGTABLET / ORALAB12019-03-2603ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A209250-004TADALAFIL20MGTABLET / ORALAB12019-03-2603ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A209250-001TADALAFIL2.5MGTABLET / ORALAB12019-03-262680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A209250-002TADALAFIL5MGTABLET / ORALAB12019-03-262680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A209250-003TADALAFIL10MGTABLET / ORALAB12019-03-262680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A209250-004TADALAFIL20MGTABLET / ORALAB12019-03-262680178bc6a6…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 5 · 176 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-10-15 13:18:302026-09A209250-001AB11c2088c7a36db…
2026-10-15 13:18:302026-09A209250-002AB11c2088c7a36db…
2026-10-15 13:18:302026-09A209250-003AB11c2088c7a36db…
2026-10-15 13:18:302026-09A209250-004AB11c2088c7a36db…
2026-09-14 22:38:342026-08A209250-001AB1184e616aacf4f…
2026-09-14 22:38:342026-08A209250-002AB1184e616aacf4f…
2026-09-14 22:38:342026-08A209250-003AB1184e616aacf4f…
2026-09-14 22:38:342026-08A209250-004AB1184e616aacf4f…
2026-08-18 06:07:402026-07A209250-001AB11caaa826d4ba7…
2026-08-18 06:07:402026-07A209250-002AB11caaa826d4ba7…
2026-08-18 06:07:402026-07A209250-003AB11caaa826d4ba7…
2026-08-18 06:07:402026-07A209250-004AB11caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A209250-001AB11011fe1cb6892…
2026-02-19 14:30 UTC2026-02A209250-002AB11011fe1cb6892…
2026-02-19 14:30 UTC2026-02A209250-003AB11011fe1cb6892…
2026-02-19 14:30 UTC2026-02A209250-004AB11011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A209250-001AB1131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A209250-002AB1131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A209250-003AB1131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A209250-004AB1131067a03dcf5…
2025-08-23 18:47 UTC2025-08A209250-001AB116a471c1ec25d…
2025-08-23 18:47 UTC2025-08A209250-002AB116a471c1ec25d…
2025-08-23 18:47 UTC2025-08A209250-003AB116a471c1ec25d…
2025-08-23 18:47 UTC2025-08A209250-004AB116a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A209250-001AB11fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A209250-002AB11fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A209250-003AB11fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A209250-004AB11fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A209250-001AB11b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A209250-002AB11b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A209250-003AB11b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A209250-004AB11b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A209250-001AB1103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A209250-002AB1103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A209250-003AB1103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A209250-004AB1103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A209250-001AB112680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A209250-002AB112680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A209250-003AB112680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A209250-004AB112680178bc6a6…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
tadalafil
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
TADALAFIL5 mg/1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
70518-3697TADALAFIL TABLET, FILM COATED [REMEDYREPACK INC.]3Current NDC20240328_b927f04e-63d2-4d3d-bc07-93d85f5a29c6.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 12 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
tadalafilTADALAFILBryant Ranch Prepack394be6ef-c0f7-4cd5-8062-39fda5c1c2c42026-08-27Warnings, Adverse reactionsExact identifier
application applno (ANDA): 209250
application number: ANDA209250
tadalafilTADALAFILNuCare Pharmaceuticals,Inc.2c277890-3c5d-5fd5-e063-6394a90af15b2026-07-24Warnings, Adverse reactionsExact identifier
application applno (ANDA): 209250
application number: ANDA209250
tadalafilTADALAFILRedpharm Drug52505a7a-e3dd-7c4e-e063-6294a90a14732026-05-21Warnings, Adverse reactionsExact identifier
application applno (ANDA): 209250
application number: ANDA209250
tadalafilTADALAFILPreferred Pharmaceuticals Inc.fee8c2be-ccfa-4c66-abed-5e232ec762ae2026-02-27Warnings, Adverse reactionsExact identifier
application applno (ANDA): 209250
application number: ANDA209250
tadalafilTADALAFILAsclemed USA, Inc.fa547e3d-455a-4926-9fd9-3499308985022025-06-25Warnings, Adverse reactionsExact identifier
application applno (ANDA): 209250
application number: ANDA209250
tadalafilTADALAFILProficient Rx LP7976c4ec-ecc4-4a49-a4fe-f990aece2d3c2025-06-01Warnings, Adverse reactionsExact identifier
application applno (ANDA): 209250
application number: ANDA209250
tadalafilTADALAFILBryant Ranch Prepack24b82a6a-1b7e-42e6-b29b-41d4ee4d525f2025-04-03Warnings, Adverse reactionsExact identifier
application applno (ANDA): 209250
application number: ANDA209250
tadalafilTADALAFILBryant Ranch Prepackff3c7dd3-2dcc-498c-a121-1e2aa62c7a972024-08-16Warnings, Adverse reactionsExact identifier
application applno (ANDA): 209250
application number: ANDA209250
tadalafilTADALAFILProficient Rx LP929e391e-b74b-4ccd-8690-16ffcece7a302024-08-01Warnings, Adverse reactionsExact identifier
application applno (ANDA): 209250
application number: ANDA209250
tadalafilTADALAFILNuCare Pharmaceuticals,Inc.13a107ba-cbbd-7760-e063-6394a90a1ee82024-03-14Warnings, Adverse reactionsExact identifier
application applno (ANDA): 209250
application number: ANDA209250
tadalafilTADALAFILUnichem Pharmaceuticals (USA), Inc.a7b3937e-ff03-436a-a5d4-92a4771034b62024-01-31Warnings, Adverse reactionsExact identifier
application applno (ANDA): 209250
application number: ANDA209250
tadalafilTADALAFILProficient Rx LPac93704f-8e33-43ba-8b56-3d61092ff1d92023-01-01Warnings, Adverse reactionsExact identifier
application applno (ANDA): 209250
application number: ANDA209250

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
70518-3697-370518369703100 POUCH in 1 BOX (70518-3697-3) / 1 TABLET, FILM COATED in 1 POUCH (70518-3697-1) 100 pouch2026-10-28NoNoCurrent